A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 3, 1996, Pages 326-330

  Aaby, Peter ^a,b,g   Samb, Badara ^a   Simondon, François ^a   Knudsen, Kim ^b   Seek, Awa Marie Coll ^c   Bennett, John ^d   Markowitz, Lauri ^e   Whittle, Hilton ^f  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d Task Force Child Survival and Devmt   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^g STATENS SERUM INSTITUT   (Denmark)

Author keywords

Edmonston Zagreb; Measles; Schwarz standard; Senegal; Vaccines

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILDHOOD MORTALITY; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; MEASLES; MEASLES VACCINATION; MORTALITY; NORMAL HUMAN; PRESCHOOL CHILD; REGRESSION ANALYSIS; RURAL AREA; SENEGAL;

EID: 0030008681     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90275-8     Document Type: Article

References (26)

1. Aaby, P., Samb, B., Simondon, F., Whittle, H., Coll Seek, A. M., Knudsen, K., Bennett, J., Markowitz, L. & Rhodes, P. (1991). Child mortality after high-titre measles vaccines in Senegal: the complete data set. Lancet, 338, 1518.
2. Aaby, P., Knudsen, K., Whittle, H., Thårup, J., Poulsen, A., Sodemann, M., Jokobsen, M., Brink, L., Gansted, U., Permin, A., Jensen, T. G., Lisse, I. M., Andersen, H. & da Silva, M. C. (1993a). Long-term survival after Edmonston-Zagreb measles vaccination: increased female mortality. Journal of Pediatrics, 122, 904-908.
3. Aaby, P., Andersen, M., Sodemann, M., Jakobsen, M., Gomes, J. & Fernandes, M. (1993b). Reduced childhood mortality following standard measles vaccination at 4-8 months compared to 9-11 months of age. British Medical Journal, 307, 1308-1311.
4. Aaby, P., Samb, B., Simondon, F., Knudsen, K., Coll Seek, A. M., Bennett, J. & Whittle, H. (1993c). Divergent mortality for male and female recipients of low-titre and high-titre measles vaccines in rural Senegal. American Journal of Epidemiology, 138, 746-755.
5. Aaby, P., Samb, B., Simondon, F., Knudsen, K., Coll Seek, A. M., Bennett, J., Markowitz, L., Rhodes, P. & Whittle, H. (1994). Sex specific mortality after high titre measles vaccines in rural Senegal. Bulletin of the World Health Organization, 72, 761-770.
6. Aaby, P., Samb, B., Simondon, F., Coll Seek, A. M., Knudsen, K. & Whittle, H. (1995). Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. British Medical Journal, 311, 481-485.
7. Aaby, P., Simondon, F., Samb, B., Knudsen, K., Coll Seek, A. M., Bennett, J., Markowitz, L. & Whittle, H. (in press). Five year follow-up of morbidity and mortality among recipients of high-litre measles vaccine. Vaccine.
8. Cox, D. R. (1972). Regression models and life tables (with discussion). Journal of the Royal Statistical Society, B, 34, 187-220.
9. Desgrées du Loû, A., Pison, G. & Aaby, P. (1995). The role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. American Journal of Epidemiology, 142, 643-652.
10. Diaz-Ortega, J. L., Luna-Abascal, M., Valdespino, J. L., Sepulveda, J., Markowitz, L. E. & Zell, E. R. (1992). Mortality and morbidity after high titre measles vaccine in Mexico. Lancet, 340, 924.
11. EPI [Expanded Programme on Immunization] (1990). Global advisory group. Weekly Epidemiological Record, 65, 5-11.
12. EPI [Expanded Programme on Immunization] (1992). Safety of high titre measles vaccines. Weekly Epidemiological Record, 67, 357-361.
13. Garenne, M. (1994). Effects of Edmonston-Zagreb high-titre vaccine on nutritional status. Lancet, 334, 261-262.
14. Garenne, M. & Aaby, P. (1990). Pattern of exposure and measles mortality in Senegal. Journal of Infectious Diseases, 161, 1088-1094.
15. Garenne, M., Maire, B., Fontaine, O., Dieng, K. & Briend, A. (1987). Risques de décès associés à différents états nutritionnels chez l'enfant d'âge préscolaire. Dakar: ORSTOM.
16. Halsey, N. (1993). Increased mortality following high titer measles vaccine: too much of a good thing. Pediatric Infectious Disease Journal, 12, 462-465.
17. Holt, E. A., Moulton, L. H., Siberry, G. K. & Halsey, N. A. (1993). Differential mortality by measles vaccine titer and sex. Journal of Infectious Diseases, 168, 1087-1096.
18. León, M. E., Ward, B., Kanashiro, R., Hernández, H., Berry, S., Vaisberg, A., Escamilla, J., Campos, M., Bellomo, S., Azabache, V. & Halsey, N. A. (1993). Immunologic parameters 2 years after high-titer measles immunization in Peruvian children. Journal of Infectious Diseases, 168, 1097-1104.
19. Lisse, I. M., Aaby, P., Whittle, H., Knudsen, K. & Andersen, H. (1994). Long-term impact of high-litre Edmonston-Zagreb measles vaccine on T-cell subsets. Pediatric Infectious Disease Journal, 13, 109-112.
20. Markowitz, L. E., Sepulveda, J., Diaz-Ortega, J. L., Valdepino, J. L., Albrecht, P., Zell, E. R., Stewart, J., Zarate, M. L. & Bernier, R. H. (1990). Immunization of six months old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. New England Journal of Medicine, 322, 580-587.
21. Rothman, K. J. (1986). Modern Epidemiology, Boston: Little, Brown.
22. Samb, B., Aaby, P., Whittle, H., Coll Seek, A. M. & Simondon, F. (1993). Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 697-701.
23. Samb, B., Whittle, H., Aaby, P., Coll Seek, A. M., Bennett, J., Markowitz, L., Ngom, P. T., Zeller, H., Michaelsen, K. F. & Simondon, F. (1995). No long-term immunosuppression after high-titre Edmonston-Zagreb measles vaccination in Senegal. Journal of Infectious Diseases, 171, 506-508.
24. Tidjani, O., Grunitsky, B., Guerin, N., Levy-Bruhl, D., Leecam, N., Xuereff, C. & Tatagan, K. (1989). Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet, ii, 1357-1360.
25. Whittle, H., Hanlon, P., O'Neill, K., Hanlon, L., Marsh, V., Jupp, E. & Aaby, P. (1988). Trial of high-dose Edmonston-Zagreb measles vaccine in The Gambia: antibody response and side-effects. Lancet, ii, 811-814.
26. Whittle, H. C., Campbell, H., Rahman, S. & Armstrong, J. R. M. (1990). Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine. Lancet, 336, 1046-1048.